155 related articles for article (PubMed ID: 20974639)
1. Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase.
Mendoza RA; Moody EE; Enriquez MI; Mejia SM; Thordarson G
J Endocrinol; 2011 Jan; 208(1):11-9. PubMed ID: 20974639
[TBL] [Abstract][Full Text] [Related]
2. Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.
Mendoza RA; Enriquez MI; Mejia SM; Moody EE; Thordarson G
J Endocrinol; 2011 Jan; 208(1):1-9. PubMed ID: 20974640
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells.
Chen S; Wu RF; Su L; Zhou WD; Zhu MB; Chen QH
Fertil Steril; 2014 Jul; 102(1):264-71. PubMed ID: 24835059
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.
Liu H; Pedram A; Kim JK
Cardiovasc Res; 2011 Jan; 89(1):119-28. PubMed ID: 20724307
[TBL] [Abstract][Full Text] [Related]
5. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
9. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
10. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
12. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
14. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
15. Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.
Behrens D; Gill JH; Fichtner I
Mol Cell Endocrinol; 2007 Aug; 274(1-2):19-29. PubMed ID: 17597290
[TBL] [Abstract][Full Text] [Related]
16. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression.
Tu Z; Li H; Ma Y; Tang B; Tian J; Akers W; Achilefu S; Gu Y
Mol Cell Biochem; 2012 Jul; 366(1-2):111-22. PubMed ID: 22476901
[TBL] [Abstract][Full Text] [Related]
17. Estrous cycle modulates ovarian carcinoma growth.
Armaiz-Pena GN; Mangala LS; Spannuth WA; Lin YG; Jennings NB; Nick AM; Langley RR; Schmandt R; Lutgendorf SK; Cole SW; Sood AK
Clin Cancer Res; 2009 May; 15(9):2971-8. PubMed ID: 19383821
[TBL] [Abstract][Full Text] [Related]
18. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of mitochondrial and nuclear p38α signaling: a novel mechanism of estrogen neuroprotection in cerebral ischemia.
Han D; Scott EL; Dong Y; Raz L; Wang R; Zhang Q
Mol Cell Endocrinol; 2015 Jan; 400():21-31. PubMed ID: 25462588
[TBL] [Abstract][Full Text] [Related]
20. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]